Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Regencell Bioscience Holdings Limited

Capitalization 12.81B 11.05B 9.98B 9.56B 17.38B 1,180B 18.17B 118B 47.23B 564B 48.08B 47.04B 2,025B P/E ratio 2024
-10.2x
P/E ratio 2025 -2,351x
Enterprise value 12.8B 11.04B 9.97B 9.56B 17.37B 1,179B 18.16B 118B 47.22B 564B 48.06B 47.03B 2,025B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
11.18%
Yield 2024 *
-
Yield 2025 -
1 day+10.92%
1 week-0.77%
Current month-1.26%
1 month-6.55%
3 months+56.02%
6 months+90.86%
Current year+23.33%
1 week 20
Extreme 20
29.01
1 month 20
Extreme 20
35.7
Current year 20
Extreme 20
69
1 year 0.1
Extreme 0.105
83.6
3 years 0.08
Extreme 0.0797
83.6
5 years 0.08
Extreme 0.0797
83.6
10 years 0.08
Extreme 0.0797
83.6
Manager TitleAgeSince
Chief Executive Officer 54 01/01/2014
Chief Operating Officer 49 01/08/2021
Director TitleAgeSince
Director/Board Member 49 28/12/2023
Director/Board Member 54 01/07/2021
Director/Board Member 65 13/12/2021
Change 5d. change 1-year change 3-years change Capi.($)
+10.92%-0.77%+23,837.15%+3,647.65% 12.81B
+1.86%-2.24%-6.91%-5.13% 44.96B
+0.39%-3.84%+22.35%+38.67% 33.54B
-4.00%-14.47%+15.30%+41.71% 30.24B
+2.33%+2.46%-6.83%-12.01% 29.97B
+1.41%-1.80%+154.50%+359.86% 19.78B
-0.30%-0.90%+64.62%+120.53% 14.73B
+1.69%+4.61%+43.79%+154.56% 13.58B
+1.76%-2.15%+23.85%+2.02% 12.97B
+1.78%-8.05%+122.89%+116.80% 12.45B
Average +1.80%-3.00%+2,427.07%+446.47% 22.5B
Weighted average by Cap. +1.24%-3.49%+1,388.45%+271.78%

Financials

2024 2025
Net sales - -
Net income -4.3M -3.71M -3.35M -3.21M -5.84M -396M -6.1M -39.56M -15.87M -190M -16.15M -15.8M -680M -3.58M -3.09M -2.79M -2.68M -4.86M -330M -5.08M -32.96M -13.22M -158M -13.45M -13.17M -567M
Net Debt -7.88M -6.79M -6.13M -5.88M -10.69M -726M -11.17M -72.43M -29.04M -347M -29.56M -28.93M -1.25B -4.35M -3.75M -3.39M -3.25M -5.91M -401M -6.17M -40.03M -16.05M -192M -16.34M -15.99M -688M
Logo Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Employees
10
Date Price Change Volume
09/03/26 25.90 $ +10.92% 315,943
06/03/26 23.35 $ -3.55% 71,076
05/03/26 24.21 $ -4.87% 51,408
04/03/26 25.45 $ +6.09% 76,371
03/03/26 23.99 $ -8.08% 165,928
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW